Immuno-Biological Laboratories Co., Ltd. (TYO:4570)

TYO:4570 Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 23, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	9,379	12,499	4,470	4,927	3,791	3,046
Market Cap Growth	109.79%	179.58%	-9.26%	29.98%	24.46%	-40.76%
Enterprise Value	8,643	11,789	3,907	4,534	3,633	2,855
Last Close Price	1007.00	1342.00	477.95	526.74	405.26	325.60

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 23, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	25.42	37.99	17.95	26.49	-	-
PS Ratio	8.69	12.45	4.61	6.04	4.77	4.71
PB Ratio	4.97	6.78	2.95	3.90	3.52	2.23
P/TBV Ratio	4.97	6.79	2.96	3.90	3.52	2.23
P/FCF Ratio	34.99	46.64	36.05	42.11	145.79	-
P/OCF Ratio	31.16	41.52	24.43	37.04	145.79	-

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 23, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	8.01	11.74	4.03	5.56	4.58	4.41
EV/EBITDA Ratio	23.76	39.43	17.44	40.48	-	-
EV/EBIT Ratio	25.05	41.95	18.70	41.22	69.86	-
EV/FCF Ratio	32.25	43.99	31.51	38.75	139.72	-

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 23, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	0.09	0.10	0.14	0.19	0.22	0.17
Debt / EBITDA Ratio	0.47	0.59	0.91	2.10	-	-
Debt / FCF Ratio	-	0.66	1.65	2.01	9.00	-
Net Debt / Equity Ratio	-0.39	-0.44	-0.41	-0.39	-0.35	-0.20
Net Debt / EBITDA Ratio	-2.02	-2.72	-2.77	-4.45	-	-
Net Debt / FCF Ratio	-	-3.03	-5.01	-4.26	-14.61	2.96
Asset Turnover	0.52	0.50	0.56	0.54	0.51	0.37
Inventory Turnover	0.79	0.86	1.05	0.94	0.83	0.85
Quick Ratio	3.74	4.23	3.76	3.60	3.30	2.99
Current Ratio	5.18	5.69	4.95	4.91	4.62	4.95
Return on Equity (ROE)	21.32%	19.60%	17.92%	15.88%	-23.63%	-17.22%
Return on Assets (ROA)	10.41%	8.78%	7.54%	4.50%	2.07%	-4.30%
Return on Capital Employed (ROCE)	17.90%	15.00%	13.40%	8.10%	4.40%	-8.30%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 23, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	3.93%	2.63%	5.57%	3.77%	-7.62%	-8.47%
FCF Yield	2.86%	2.14%	2.77%	2.38%	0.69%	-3.05%
Dividend Yield	0.74%	0.45%	-	-	-	-
Total Shareholder Return	0.74%	0.45%	-	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 7, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 23, 2026

Data Sources Report a data error